RXO (NYSE:RXO – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities researchers at Benchmark in a note issued to investors on Wednesday,Benzinga reports.
RXO has been the subject of a number of other research reports. Wells Fargo & Company lowered their price target on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a report on Tuesday, January 7th. The Goldman Sachs Group restated a “neutral” rating and set a $29.00 target price on shares of RXO in a research report on Monday, November 18th. Citigroup cut RXO from a “buy” rating to a “neutral” rating and set a $33.00 price target on the stock. in a report on Tuesday, November 12th. Jefferies Financial Group dropped their price objective on RXO from $33.00 to $30.00 and set a “buy” rating for the company in a report on Friday, January 10th. Finally, Susquehanna lowered their price target on shares of RXO from $16.00 to $12.00 and set a “negative” rating for the company in a research report on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, RXO has a consensus rating of “Hold” and a consensus target price of $26.77.
Read Our Latest Stock Analysis on RXO
RXO Price Performance
RXO (NYSE:RXO – Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $956.19 million. During the same quarter in the prior year, the firm earned $0.05 EPS. The company’s revenue was up 6.6% on a year-over-year basis. Equities research analysts forecast that RXO will post 0.12 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. FMR LLC lifted its holdings in shares of RXO by 439.5% during the 3rd quarter. FMR LLC now owns 47,837 shares of the company’s stock valued at $1,339,000 after purchasing an additional 38,970 shares in the last quarter. Harbor Capital Advisors Inc. bought a new position in RXO in the fourth quarter valued at approximately $2,004,000. Primecap Management Co. CA boosted its holdings in shares of RXO by 20.7% in the second quarter. Primecap Management Co. CA now owns 1,020,900 shares of the company’s stock valued at $26,697,000 after buying an additional 175,300 shares during the period. Citigroup Inc. increased its position in shares of RXO by 132.4% during the third quarter. Citigroup Inc. now owns 196,748 shares of the company’s stock worth $5,509,000 after acquiring an additional 112,073 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of RXO by 7.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,068,380 shares of the company’s stock worth $57,915,000 after acquiring an additional 136,886 shares during the period. 92.73% of the stock is owned by institutional investors and hedge funds.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Further Reading
- Five stocks we like better than RXO
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- The Basics of Support and Resistance
- Can Integrated Healthcare Stocks Succeed in Public Markets?
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.